NCT03233529View on ClinicalTrials.gov

Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

May 4, 2018

Study Completion Date

May 4, 2018

Conditions
Dermatitis, Atopic
Interventions
DRUG

Crisaborole ointment 2% BID

Crisaborole ointment 2% BID for 15 days (double blind); additional 28 days (open label)

DRUG

Placebo ointment (vehicle)

Placebo ointment (vehicle) BID for 15 days (double blind)

Trial Locations (1)

H2K 4L5

Innovaderm Research Incorporated, Montreal

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY